Adagio Medical announces strategic restructuring

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. ALHC
3. SPCX
4. PEP
5. CVS
6. T
7. UNH
8. AXP
9. RTX
10. ZETA

Go back to Adagio Medical announces strategic restructuring

Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation

February 28, 2025 8:30 AM EST

LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- Adagio Medical Holdings, Inc. (Nasdaq: ADGM; the Company), a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, today announced a corporate restructuring and realignment of resources to prioritize its FULCRUM-VT US pivotal investigational device exemption (Pivotal IDE) clinical trial activities and its new product design optimization program. After a comprehensive strategic review, we are doubling down on the priorities that will drive the most meaningful impact for physicians, patients, and shareholders, said Todd Usen, the Chief Executive Officer of Adagio. Our resources are now focused on the completion of the FULCRUM-VT... More